Locations:
Search IconSearch
October 5, 2015/Neurosciences/Outcomes

Outcomes Snapshot: Rates of Long-Term Seizure Freedom After Epilepsy Surgery

Examining 18 years of surgical outcomes

EpilepsySurg-690×380

Cleveland Clinic Epilepsy Center staff recently examined 18 years of epilepsy surgery outcomes data from more than 2,000 patients to evaluate patients’ long-term chances of achieving and maintaining seizure freedom. Seizure outcomes were classified using the widely accepted Engel classification1 of seizure freedom (seizure-free = Engel class 1).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

As detailed in the graph and table below, approximately 60 percent of patients with previously medically intractable epilepsy remained seizure-free 10 years after surgical treatment at Cleveland Clinic’s Epilepsy Center. Individual curves for adult patients and pediatric patients who underwent epilepsy surgery at the center from 1996 to 2014 show similar long-term chances of seizure freedom between these two populations.

EpilepsySurg-inset1

EpilepsySurg-inset2

These data are a sampling of what’s included in the newly released 2014 Outcomes book from Cleveland Clinic’s Neurological Institute. The book is one in a series of Outcomes books issued each year by more than a dozen of Cleveland Clinic’s institutes for the purpose of enabling evaluation of care delivery in common areas of medical and surgical treatment. The books, which are intended for a physician audience, benefit outside clinicians by helping inform potential referral or consultation decisions. The process of outcomes collection and analysis behind the books benefits Cleveland Clinic by guiding continuous improvement efforts and yielding data to generate research questions.

For free access to the online version of the 2014 Neurological Institute Outcomes book, which also includes profiles of new technologies and innovations from the Neurological Institute, click here.

Reference

  1. Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel J Jr., ed. Surgical Treatment of the Epilepsies. 2nd ed. New York, NY: Raven Press;1993:609-621.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad